0310-0482Level 3
IRESSA (Gefitinib)
**Product type:** Human Prescription Drug
**Active ingredient:** GEFITINIB
**Strength:** 250 mg/1
**Dosage form:** Tablet, Coated
**Route:** Oral
**Labeler:** AstraZeneca Pharmaceuticals LP
**Marketing category:** NDA (NDA206995)
**Pharmacologic class:** Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0310-0482Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.